FDA Approves Gadavist For Central Nervous System Scans

Links shared publicly online about this topic.

  • 436
    total visits

FDA Approves Gadavist For Central Nervous System Scans

medicalnewstoday.com

The U.S. Food and Drug Administration approved Gadavist (gadobutrol), a gadolinium-based contrast agent, for use in patients undergoing magnetic resonance imaging (MRI) of the central nervous syst

View full resource at medicalnewstoday.com

Tags: Nervous System, Diet and Nutrition, Drug, Imaging Tests, Magnetic Resonance Imaging, FDA

  • Share

Most Recently Shared on March 16, 2011 at 10:05 am By:

mnt_neurology MNT Neurology News

FDA Approves Gadavist For Central Nervous System Scans http://mnt.to/3Sjw #neurology

1 year ago...

Also Shared By:

MNT Drug Approvals MNT Drug Approvals

MNT MRI / Ultrasound MNT MRI / Ultrasound

U.S. FDA Approves Bayer's Gadavist (gadobutrol) Injection for MRI of the Central Nervous System

drugs.com — “Gadavist (gadobutrol) is used in diagnostic magnetic resonance imaging. Includes Gadavist side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 15, 2011 at 11:42 pm By:

drugscom Drugs.com Health Site

U.S. FDA Approves Bayer's Gadavist (gadobutrol) Injection for MRI of the Central Nervous System - http://bit.ly/eXw8ST

1 year ago...

U.S. FDA Approves Bayer's Gadavist (gadobutrol) Injection for MRI of the Central Nervous System

drugs.com — “Gadavist (gadobutrol) is used in diagnostic magnetic resonance imaging. Includes Gadavist side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 15, 2011 at 10:07 pm By:

Drugs_Devices Drugs and Devices OW OW Health

U.S. FDA Approves Bayer's Gadavist (gadobutrol) Injection for MRI of the Central Nervous System: WAYNE, N.... http://bit.ly/fDYi45 #drug

1 year ago...

FDA panel backs Bayer imaging drug | Reuters

reuters.com — “WASHINGTON (Reuters) - U.S. advisers on Friday recommended approval of a Bayer AG imaging drug for use with magnetic resonance imaging scans of the central nervous system. A Food and Drug AdministrationView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on January 21, 2011 at 8:46 pm By:

U.S. FDA panel backs Bayer imaging drug | Reuters

reuters.com — “WASHINGTON (Reuters) - U.S. advisers on Friday recommended approval of a Bayer AG imaging drug for use with magnetic resonance imaging scans of the central nervous system. A Food and Drug AdministrationView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on January 21, 2011 at 6:50 pm By:

U.S. FDA panel backs Bayer imaging drug

health.yahoo.net — “U.S. advisers on Friday recommended approval of a Bayer AG imaging drug for use with magnetic resonance imaging scans of the central nervous system.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on January 21, 2011 at 6:35 pm By:

U.S. FDA panel backs Bayer imaging drug | Reuters

reuters.com — “WASHINGTON (Reuters) - U.S. advisers on Friday recommended approval of a Bayer AG imaging drug for use with magnetic resonance imaging scans of the central nervous system. A Food and Drug AdministrationView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on January 21, 2011 at 6:29 pm By:

FDA panel grants minimal approval for Lilly's PET compound

healthimaging.com — “The FDA Peripheral and Central Nervous System Drugs Advisory Committee decided Jan. 20 that it could not recommend approval of florbetapir (Amyvid, Eli Lilly) based on the currently available data (13-3); but voted unanimously (16-0) to recommend approval of Amyvid conditional on a reader training program that demonstrates reader accuracy and consistency through a re-read of previously acquired scans.View full resource at healthimaging.com

  • View Related
  • Share

Most Recently Shared on January 21, 2011 at 4:25 am By:

HealthImaging Health Imaging & IT Health Magazine

FDA panel grants minimal approval for Lilly's PET compound - The FDA Peripheral and Central Nervous System Drugs Adv... http://ow.ly/1aXCTS

1 year ago...

Advertisement